Icon

JOURNAVX - (50MG)

SUZETRIGINE None
50MG
Less Than $1000 mn
None None
None None
None None
JOURNAVX is a sodium channel blocker indicated for the treatment of moderate to severe acute pain in adults.
Yes
JOURNAVX Patent 1
*** *********

Download ParaIV Report


Download ParaIV Detailed Report


To get detailed report Contact Us

ParaIV Advanced Search






Drug Name Generic Name Dosage Route of Administration Probable FTF Known Para IV Filers Other ANDA Developers

Please contact contact@researchdelta.com to get more details.